EVALUATION OF DNA REPAIR FUNCTION AS A PREDICTOR OF RESPONSE IN A CLINICAL TRIAL OF PARP INHIBITOR MONOTHERAPY FOR RECURRENT OVARIAN CARCINOMA

University Of Washington, Seattle WA

Investigators